RxDoctor Payments Data

Priyanka Mude

Foot Surgery · North Canton, OHNPI 1770996662

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Amgen at 36.7% of the total. Reporting peaked in 2019 at $723 and has fallen 95.5% since, to $33 in 2025.

$2,011in general payments, 2019–2025

Across 167 payments — averaging $12.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$738
  • Smith+Nephew$577
  • Organogenesis Inc.$120
  • Paratek Pharmaceuticals, Inc.$95
  • Mimedx Group, Inc.$65
  • Osiris Therapeutics Inc.$57
  • plus $359 from 15 others

What the payments were for

  • Speaking & faculty fees$553%
  • Food & beverage$1,95697%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,011 in reported general payments places this provider in the 70th percentile of 28 foot surgery providers in Ohio.

See all foot surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$50,078
Medicare patients
110
Services billed
615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox58$1,047
Econazole Nitrate39$794
Ammonium Lactate33$269
Triamcinolone Acetonide26$244
Ketoconazole24$242
Doxycycline Hyclate19$130
Methylprednisolone30$113

Paid to pharmacies, not to this prescriber.

Other foot surgery in North Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →